A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
IPI-926 is an inhibitor of the hedgehog pathway. IPI-926 may improve therapeutic outcomes in patients with Chondrosarcoma.
Epistemonikos ID: f3771967ae099a0f923b8888525d5d74cfedf9b7
First added on: May 06, 2024